BioSpace News Archive

Deals

A Look at 5 Big and Interesting Biotech IPOs for 2019

Here’s a look at some of the biggest U.S. Nasdaq-based initial public offerings in 2019 and some of the more intriguing ones.

December 20, 2019
·
3 min read
·
Mark Terry
Business

Global Blood Therapeutics Strikes Agreement with Syros to Develop Next-Generation Sickle Cell Disease Treatment

Less than a month after snagging approval for a first-of-its-kind sickle cell disease treatment, Global Blood Therapeutics (GBT) is already looking at next-generation measures to tackle the disorder, as well as other diseases of the blood such as beta thalassemia.

December 20, 2019
·
3 min read
·
Alex Keown
Pharm Country

As Part of Strategic Refocusing, AstraZeneca Sells Rights to 2 Cancer Drugs and More

As part of strategic refocusing, AstraZeneca sold the rights to two cancer drugs in several countries in Europe, Africa and other countries to Juvisé Pharmaceuticals.

December 20, 2019
·
2 min read
·
Mark Terry
Business

Government Continues Crackdown on Nondisclosure of Chinese Research Funding

The U.S. Government is increasing the measures it is taking to counter what it sees as a growing threat to scientific intellectual property from China.

December 20, 2019
·
3 min read
·
Alex Keown
Bio NC

Clinical Catch-Up: December 16-20

Heading into the holidays, there was still plenty of clinical trial news last week. Here’s a look.

December 20, 2019
·
9 min read
·
Mark Terry
FDA

FDA Clears Their Desk for the End-of-the-Year Push: Ebola, Urothelial Cancer, Compounding Drugs and Opioids

Moving into the holidays and the fast-approaching end of the year, the U.S. Food and Drug Administration (FDA) got busy wrapping up a number of to-do items. Here’s a look.

December 20, 2019
·
3 min read
·
Mark Terry
Bio NC

6 Sticky Interview Situations and How to Handle Them

Job interviewing can be an unnerving experience, but if you know how to handle some of the stickiest situations encountered in interviewing, you can be that much more confident.

December 20, 2019
·
4 min read
·
Katharine Hansen, PhD
FDA

Most Important Drugs Over the Past 10 Years

Looking back over the past year and even decade, STAT News takes a look back at the best drugs approved over the past 10 years in its weekly Readout podcast.

December 20, 2019
·
3 min read
·
Alex Keown
Drug Development

Stealth Bio Faces Setback in Failed Mitochondrial Disease Trial

Boston-based Stealth BioTherapeutics reported that its Phase III MMPOWER-3 clinical trial of elamipetride failed to meet its primary endpoint.

December 20, 2019
·
3 min read
·
Mark Terry
Deals

Johnson & Johnson Announces Agreement to Acquire Remaining Stake in Verb Surgical Inc.

Dedicated to shaping the next frontier of surgery, Johnson & Johnsoni (NYSE: JNJ) today announced an agreement to acquire the remaining stake in Verb Surgical Inc. following a successful strategic collaboration with Verily, an Alphabet company.

December 20, 2019
·
6 min read